← All organizations
Highest phase reached
Phase 3
First clinical trial
Jul 1, 2012Last known activity
Aug 15, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (2 distinct, 2 trials)
Indications
Studied for
Recent trials (5)
- NCT06549842Sponsor investigatorN/AAug 15, 2024
- NCT06549842OfficialN/AAug 15, 2024
- NCT06549842Lead sponsorN/AAug 15, 2024
- NCT01580683Lead sponsorPhase 3Jul 1, 2012
- NCT01580683Reponsible party - principal investigatorPhase 3Jul 1, 2012
Details
- Last known activity
- Aug 15, 2024